BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11064353)

  • 21. Current treatment of high grade osteosarcoma of the extremity: review.
    Bacci G; Lari S
    J Chemother; 2001 Jun; 13(3):235-43. PubMed ID: 11450880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
    Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
    Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients.
    Tunn PU; Reichardt P
    Onkologie; 2007 May; 30(5):228-32. PubMed ID: 17460416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy for osteosarcoma without high-dose methotrexate: another piece in the puzzle.
    Blay JY
    Onkologie; 2007 May; 30(5):226-7. PubMed ID: 17460415
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.
    Link MP; Goorin AM; Miser AW; Green AA; Pratt CB; Belasco JB; Pritchard J; Malpas JS; Baker AR; Kirkpatrick JA
    N Engl J Med; 1986 Jun; 314(25):1600-6. PubMed ID: 3520317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
    Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
    Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restoration of ovarian function after chemotherapy for osteosarcoma.
    Wikström AM; Hovi L; Dunkel L; Saarinen-Pihkala UM
    Arch Dis Child; 2003 May; 88(5):428-31. PubMed ID: 12716717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of neoadjuvant chemotherapy for patients with stage II osteosarcoma].
    Guo W; Tang XD; Liu J; Yang Y
    Zhonghua Wai Ke Za Zhi; 2009 Nov; 47(21):1634-7. PubMed ID: 20137398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant chemotherapy for malignant fibrous histiocytoma of bone and for osteosarcoma of the limbs: a comparison between the results obtained for 21 and 144 patients, respectively, treated during the same period with the same chemotherapy protocol.
    Bacci G; Mercuri M; Ruggieri P; Ferraro A; Bertoni F; Tella G; Ferrari S; Iantorno D
    Chir Organi Mov; 1996; 81(2):139-53. PubMed ID: 8968117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).
    Ferrari S; Meazza C; Palmerini E; Tamburini A; Fagioli F; Cozza R; Ferraresi V; Bisogno G; Mascarin M; Cefalo G; Manfrini M; Capanna R; Biagini R; Donati D; Picci P
    Tumori; 2014; 100(6):612-9. PubMed ID: 25688494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
    Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
    Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemotherapy for osteosarcoma of the extremities. Good response of the primary tumor after preoperative chemotherapy with high-dose methotrexate followed by cisplatinum and adriamycin. Preliminary results.
    Bacci G; Avella M; Brach Del Prevert A; Capanna R; Fiorentini G; Malaguti C; Picci P; Rosito P; Campanacci M
    Chemioterapia; 1988 Apr; 7(2):138-42. PubMed ID: 3165058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin.
    Bacci G; Picci P; Ruggieri P; Mercuri M; Avella M; Capanna R; Brach Del Prever A; Mancini A; Gherlinzoni F; Padovani G
    Cancer; 1990 Jun; 65(11):2539-53. PubMed ID: 2337871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
    Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
    Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results.
    Bacci G; Picci P; Ferrari S; Sangiorgi L; Mercuri M; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Comandone A
    Chir Organi Mov; 1995; 80(1):1-10. PubMed ID: 7641534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J.
    Iwamoto Y; Tanaka K; Isu K; Kawai A; Tatezaki S; Ishii T; Kushida K; Beppu Y; Usui M; Tateishi A; Furuse K; Minamizaki T; Kawaguchi N; Yamawaki S
    J Orthop Sci; 2009 Jul; 14(4):397-404. PubMed ID: 19662473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant high-dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma.
    Weiner MA; Harris MB; Lewis M; Jones R; Sherry H; Feurer EJ; Johnson J; Lahman E
    Cancer Treat Rep; 1986 Dec; 70(12):1431-2. PubMed ID: 3466693
    [No Abstract]   [Full Text] [Related]  

  • 38. Received dose and dose-intensity of chemotherapy and outcome in nonmetastatic extremity osteosarcoma. European Osteosarcoma Intergroup.
    Lewis IJ; Weeden S; Machin D; Stark D; Craft AW
    J Clin Oncol; 2000 Dec; 18(24):4028-37. PubMed ID: 11118463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
    Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P
    Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
    Thiele OC; Freier K; Bacon C; Egerer G; Hofele CM
    Br J Oral Maxillofac Surg; 2008 Oct; 46(7):533-6. PubMed ID: 18436357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.